These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 28941639)

  • 1. The role of the immune system in Alzheimer disease: Etiology and treatment.
    Jevtic S; Sengar AS; Salter MW; McLaurin J
    Ageing Res Rev; 2017 Nov; 40():84-94. PubMed ID: 28941639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is the regulation of immune system in Alzheimer's disease effective? ].
    Shirakawa H
    Nihon Yakurigaku Zasshi; 2016 May; 147(5):319. PubMed ID: 27181729
    [No Abstract]   [Full Text] [Related]  

  • 3. Innate Immunity Fights Alzheimer's Disease.
    Guillot-Sestier MV; Doty KR; Town T
    Trends Neurosci; 2015 Nov; 38(11):674-681. PubMed ID: 26549882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation, immunity, and Alzheimer's disease.
    Town T
    CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):129-31. PubMed ID: 20205648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inflammation and Alzheimer's disease].
    de Toledo M
    Rev Neurol; 2006 Apr 1-15; 42(7):433-8. PubMed ID: 16602061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer's disease.
    Popović M; Caballero-Bleda M; Puelles L; Popović N
    Int J Neurosci; 1998 Sep; 95(3-4):203-36. PubMed ID: 9777440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapies.
    Liu YH; Zeng F; Wang YR; Zhou HD; Giunta B; Tan J; Wang YJ
    Drug Discov Today; 2013 Dec; 18(23-24):1212-20. PubMed ID: 23954180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer's Disease.
    Lewcock JW; Schlepckow K; Di Paolo G; Tahirovic S; Monroe KM; Haass C
    Neuron; 2020 Dec; 108(5):801-821. PubMed ID: 33096024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immunity and the etiology of late-onset Alzheimer's disease.
    Eikelenboom P; van Exel E; Veerhuis R; Rozemuller AJ; van Gool WA; Hoozemans JJ
    Neurodegener Dis; 2012; 10(1-4):271-3. PubMed ID: 22261470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Targets in Innate Immunity to Tackle Alzheimer's Disease.
    Serradas ML; Ding Y; Martorell PV; Kulińska I; Castro-Gomez S
    Cells; 2024 Aug; 13(17):. PubMed ID: 39272998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease.
    Simard AR; Rivest S
    Mol Psychiatry; 2006 Apr; 11(4):327-35. PubMed ID: 16491130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment.
    Serpente M; Bonsi R; Scarpini E; Galimberti D
    Neuroimmunomodulation; 2014; 21(2-3):79-87. PubMed ID: 24557039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation of the brain in Alzheimer's disease: implications for therapy.
    McGeer PL; McGeer EG
    J Leukoc Biol; 1999 Apr; 65(4):409-15. PubMed ID: 10204568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential immunotherapy for Alzheimer disease and age-related dementia.
    Schwartz M; Arad M; Ben-Yehuda H
    Dialogues Clin Neurosci; 2019 Mar; 21(1):21-25. PubMed ID: 31607777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglia in Alzheimer's disease: A target for immunotherapy.
    Wang S; Colonna M
    J Leukoc Biol; 2019 Jul; 106(1):219-227. PubMed ID: 30725482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perturbation of the transcriptome: implications of the innate immune system in Alzheimer's disease.
    Song F; Qian Y; Peng X; Han G; Wang J; Bai Z; Crack PJ; Lei H
    Curr Opin Pharmacol; 2016 Feb; 26():47-53. PubMed ID: 26480202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.
    Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C
    Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the hematopoietic system for the treatment of Alzheimer's disease.
    Lampron A; Gosselin D; Rivest S
    Brain Behav Immun; 2011 Jun; 25 Suppl 1():S71-9. PubMed ID: 21195165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alzheimer's disease and the immune system response].
    Akiyama H
    Nihon Rinsho; 1994 Nov; 52(11):2990-4. PubMed ID: 7996699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease: Innate immunity gone awry?
    VanItallie TB
    Metabolism; 2017 Apr; 69S():S41-S49. PubMed ID: 28129888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.